Hansoh Pharmaceutical Group Company Limited (HKG:3692)
32.56
-0.50 (-1.51%)
Jul 21, 2026, 4:08 PM HKT
HKG:3692 Stock Forecast
Stock Price Forecast
According to 22 analysts polled by S&P Global, HKG:3692 stock has a consensus rating of "Strong Buy" and an average price target of $46.60. The average 1-year stock price forecast is 43.12% higher than the current stock price, while the lowest is $38.83 (+19.26%) and the highest is $52.90 (+62.47%).
Price Target: $46.60 (+43.12%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for HKG:3692 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 19 | 18 | 18 | 16 | 16 | 16 |
| Buy | 4 | 5 | 5 | 5 | 5 | 5 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 1 | 1 | 1 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 25 | 25 | 25 | 22 | 22 | 22 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Huatai Securities No rating | Huatai Securities | Buy Maintains $44.68 | Buy | Maintains | $44.68 | +37.22% | Jul 16, 2026 |
Unknown Analyst UBS No rating | UBS | Buy Maintains $48.80 | Buy | Maintains | $48.80 | +49.88% | Jul 14, 2026 |
Unknown Analyst Morgan Stanley No rating | Morgan Stanley | Buy Maintains $45.00 | Buy | Maintains | $45.00 | +38.21% | Jul 14, 2026 |
Unknown Analyst HSBC No rating | HSBC | Buy Maintains $49.50 | Buy | Maintains | $49.50 | +52.03% | Jul 10, 2026 |
Unknown Analyst Guosheng Securities No rating | Guosheng Securities | Buy Maintains $40.61 | Buy | Maintains | $40.61 | +24.72% | Jun 19, 2026 |
Financial Forecast
Revenue This Year
16.94B
from 15.03B
Increased by 12.73%
Revenue Next Year
18.49B
from 16.94B
Increased by 9.15%
EPS This Year
0.99
from 0.93
Increased by 5.93%
EPS Next Year
1.07
from 0.99
Increased by 8.80%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.